Research Focus

Former Employee. Graduate Staff; NE Rotating Housestaff

Recent additions – View all

1. Targeting anti-apoptotic bcl-2 family members with ABT-737 compliments the activity of bortezomib and conventional agents in in vitro models of lymphoproliferative malignancies

   Meeting Abstract

   Paoluzzi, L.; Gonen, M.; Gardner, J. R.; Heaney, M.; O'Connor, O. A.
   Cancer Research (2007)

   Fulltext@MSK | Save
2. Mechanistic rationale and clinical evidence for the efficacy of proteasome inhibitors against indolent and mantle cell lymphomas

   Journal Article

   Paoluzzi, L.; O'Connor, O. A.
   BioDrugs (2006)

   Fulltext@MSK | Save
3. Targeting antiapoptotic Bcl-2 family members with AT-101 in pre-clinical models of aggressive lymphoma in combination with cyclophosphamide (C) and rituximab (R) produces a marked improvement in therapeutic efficacy

   Meeting Abstract

   Paoluzzi, L.; Gonen, M.; Toner, L.; Smith, E.; Yang, D.; Holmund, J.; Sorensen, M.; O'connor, O.
   Blood (2005)

   Fulltext@MSK | Save